Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway
Osteoporosis is a chronic inflammatory disease that severely affects quality of life. <i>Cornus officinalis</i> is a Chinese herbal medicine with various bioactive ingredients, among which morroniside is its signature ingredient. Although anti-bone resorption drugs are the main treatment...
Saved in:
Main Authors: | Jirimutu Xiao (Author), Qiuge Han (Author), Ziceng Yu (Author), Mengmin Liu (Author), Jie Sun (Author), Mao Wu (Author), Heng Yin (Author), Jingyue Fu (Author), Yang Guo (Author), Lining Wang (Author), Yong Ma (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways
by: Xiao Chen, et al.
Published: (2018) -
Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway In vitro and Protects Against Osteoporosis in Postmenopausal Mice
by: Yongjie Chen, et al.
Published: (2022) -
Pellino1 promoted inflammation in lung injury model of sepsis by TRAF6/ NF-κB signal pathway
by: Xiaqing Liu, et al.
Published: (2021) -
CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway
by: Jinchuan Yan, et al.
Published: (2015) -
Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation
by: Xiangjiao Yi, et al.
Published: (2022)